http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1568372-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
| filingDate | 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1568372-A1 |
| titleOfInvention | Administration of enoxaparin sodium to patients with severe renal impairment |
| abstract | Methods having novel enoxaparin sodium dosing regimens for patients withnsevere renal impairment are disclosed. The methods may be used for one ornmore of preventing thrombotic episodes, treating thrombotic episodes,npreventing postoperative venous thrombosis, controlling thrombosis and/orndecreasing blood hypercoagulation and/or hemorrhaging risks, treating unstablenangina, and treating non-Q-wave myocardial infarction in human patients withnsevere renal impairment. The methods of preventing thrombotic episodes,ntreating t hrombotic episodes, preventing postoperative venous thrombosis, andncontroling thrombosis and/or decreasing blood hypercoagulation and/ornhemorrhaging risks, comprise administering from more than 20 mg to less thann40 mg, from 25 mg to 35 mg, about 30 mg, or 30 mg of enoxaparin sodium to thenpatient once daily. The methods of treating unstable angina, and non-Q-wavenmyocardial infarction comprise administering from more than 0.5 mg/kg bodynweight to less than 1.5 mg/kg body weight, or about 1 mg/kg body weight ofnenoxaparin sodium once daily. Articles of manufacture comprising enoxaparinnsodium and instructions for the use of the enoxaprin sodium are also disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010106519-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2233145-A1 |
| priorityDate | 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.